A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
This report contains market size and forecasts of Single-Use Technology for Biopharmaceuticals in Global, including the following market information:
- Global Single-Use Technology for Biopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Single-Use Technology for Biopharmaceuticals market was valued at 4454 million in 2021 and is projected to reach US$ 8388.3 million by 2028, at a CAGR of 9.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protective Clothing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Single-Use Technology for Biopharmaceuticals include Applikon Biotechnology, BioPure Technology, DowDuPont, EMD Millipore, GE Healthcare, Novasep, Pall, Saint-Gobain and Sartorius, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Single-Use Technology for Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single-Use Technology for Biopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Single-Use Technology for Biopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
- Protective Clothing
- Syringes
- Pipettes and Pipette Tips
- Flasks, Dishes, Sample and Centrifuge Vials
- Simple Cultivation Systems
Global Single-Use Technology for Biopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Single-Use Technology for Biopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Global Single-Use Technology for Biopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Single-Use Technology for Biopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Single-Use Technology for Biopharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Single-Use Technology for Biopharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Applikon Biotechnology
- BioPure Technology
- DowDuPont
- EMD Millipore
- GE Healthcare
- Novasep
- Pall
- Saint-Gobain
- Sartorius
- Thermo Fisher Scientific
- W. L. Gore and Associates
